"Early work shows that a group of compounds called peroxisome proliferator-activated receptor-gamma, or PPARgamma, inhibitors may have an unexpected cancer-fighting effect, according to research published in the journal International Cancer Research."

"Furthermore, the new studies suggest that PPARgamma inhibitors act through some of the same mechanisms as the blockbuster chemotherapy Taxol, but with key differences, says first
... read the whole article